Drug for treatment of uterine hypertrophy

Abstract

The present invention discloses a drug for treatment of uterine hypertrophy to solve treatment problem of uterine hypertrophy. The drug is characterized by being prepared by processing a plurality of traditional Chinese medicines. The raw material formulation includes by weight: 10-20 parts of maclura cochinchinensis, 8-15 parts of cladostachys amaranthoides, 8-15 parts of alyxia sinensis champ.ex benth., 6-10 parts of root of catclaw buttercup, 6-10 parts of gold buckwheat stem leaf, 8-15 parts of dodder, 6-10 parts of chinese starjasmine stem, 8-15 parts of angelica sinensis, and 3-6 parts of alpinia japonica. Clinical experiments prove that the drug for treatment of uterine hypertrophy has the characteristics of good efficacy and high safety, and is worthy of clinical application and promotion.

Description

technical field

[0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating uterine hypertrophy. Background technique

[0002] Uterine hypertrophy, also known as diffuse uterine myohypertrophy (DUMH), refers to a disease in which the uterus is uniformly enlarged, the thickness of the muscle layer exceeds 2.5 cm, and it is accompanied by varying degrees of uterine bleeding. The basic pathological changes of uterine hypertrophy are the changes of smooth muscle cells and blood vessel walls in the myometrium. Generally, it can be seen that the uterus is uniformly enlarged, and the muscle layer is 2.5-3.2 cm thick. The cut surface is off-white or pink, with increased hardness, and the fiber bundles are arranged in a braided shape. Vascular bulges in the outer 1 / 3 of the muscular layer, with normal or thickened intima, sometimes accompanied by small leiomyomas (less than 1 cm in diameter) or intimal polyps.

[0003] The eti...